Muriglan Stephanie J, Ramirez-Montagut Teresa, Alpdogan Onder, Van Huystee Thomas W, Eng Jeffrey M, Hubbard Vanessa M, Kochman Adam A, Tjoe Kartono H, Riccardi Carlo, Pandolfi Pier Paolo, Sakaguchi Shimon, Houghton Alan N, Van Den Brink Marcel R M
Department of Medicine and Immunology, Memorial Sloan-Kettering Cancer Center, Kettering 425, Mailbox 111, 1275 York Ave., New York, NY 10021, USA.
J Exp Med. 2004 Jul 19;200(2):149-57. doi: 10.1084/jem.20040116. Epub 2004 Jul 12.
Glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) is a member of the tumor necrosis factor receptor (TNFR) family that is expressed at low levels on unstimulated T cells, B cells, and macrophages. Upon activation, CD4(+) and CD8(+) T cells up-regulate GITR expression, whereas immunoregulatory T cells constitutively express high levels of GITR. Here, we show that GITR may regulate alloreactive responses during graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT). Using a BMT model with major histocompatibility complex class I and class II disparity, we demonstrate that GITR stimulation in vitro and in vivo enhances alloreactive CD8(+)CD25(-) T cell proliferation, whereas it decreases alloreactive CD4(+)CD25(-) proliferation. Allo-stimulated CD4(+)CD25(-) cells show increased apoptosis upon GITR stimulation that is dependent on the Fas-FasL pathway. Recipients of an allograft containing CD8(+)CD25(-) donor T cells had increased GVHD morbidity and mortality in the presence of GITR-activating antibody (Ab). Conversely, recipients of an allograft with CD4(+)CD25(-) T cells showed a significant decrease in GVHD when treated with a GITR-activating Ab. Our findings indicate that GITR has opposite effects on the regulation of alloreactive CD4(+) and CD8(+) T cells.
糖皮质激素诱导的肿瘤坏死因子受体家族相关基因(GITR)是肿瘤坏死因子受体(TNFR)家族的成员,在未受刺激的T细胞、B细胞和巨噬细胞上低水平表达。激活后,CD4(+)和CD8(+) T细胞会上调GITR表达,而免疫调节性T细胞则组成性地高表达GITR。在此,我们表明GITR可能在异基因骨髓移植(BMT)后的移植物抗宿主病(GVHD)期间调节同种异体反应性应答。使用具有主要组织相容性复合体I类和II类差异的BMT模型,我们证明体外和体内的GITR刺激可增强同种异体反应性CD8(+)CD25(-) T细胞增殖,而降低同种异体反应性CD4(+)CD25(-)增殖。GITR刺激后,同种异体刺激的CD4(+)CD25(-)细胞凋亡增加,这依赖于Fas-FasL途径。在存在GITR激活抗体(Ab)的情况下,含有CD8(+)CD25(-)供体T细胞的同种异体移植受者的GVHD发病率和死亡率增加。相反,用GITR激活Ab治疗时,具有CD4(+)CD25(-) T细胞的同种异体移植受者的GVHD显著降低。我们的研究结果表明,GITR对同种异体反应性CD4(+)和CD8(+) T细胞的调节具有相反的作用。